Medlab Efficacy Magazine

Medlab's New EfficacyTM Magazine

A true integrative approach to medicine and health

Issue 3: March 2017 - May 2017

Neonatal Health and Immunity

Medlab’s quarterly magazine designed to educate and update Practitioners with Medlab research and industry advancements with a variety of contributing authors. Register or log in to view today.

Featured News

NutraIngredient Awards 2017 Finalist

We are proud to announce Medlab's NRGBiotic™ is a finalist for the NutraIngredient Awards 2017 - Readers' Food Supplement of the Year!
NRGBioticTM is a valuable addition to many Practitioners 'toolbox' and is equally loved by those that use the product. The current clinical research outcomes have provided a novel adjunct option for those with Depression
Seek advice from your healthcare Practitioner. Find out more about NRGBiotic:


Mg Optima™ Relax Featured product

NanoCelleTM Range

Want more information on Medlab’s sub-micron delivery platform NanoCelleTM? Cick here for more information.

Our NanoCelle™ nutraceutical range currently includes four vitamin oral-buccal sprays, that offer superior absorption to that of a capsule, tablet or emulsion.

More Information


General Practice Conference & Exhibition 2017


Professor Luis Vitetta will present on: 'Mitigating Chronic Disease'
Please visit Medlab at stand 1138.
When: 19-21 May, 2017
Where: Sydney Showground, Sydney Olympic Park, NSW


New NanoCelleTM NanoStatTM could help tackle high cholesterol

Featured on Channel Nine News on the 9th of March 2017

Congratulations to Michael Thomsen on being the recipient of a Francis M Hooper RHD scholarship from the University of Sydney.

Michael Thomsen

Sean Hall (CEO) in March 2017 presented at The 2nd Probiotics Congress: Asia on ‘Mitigating Chronic Disease’

Probiotics Congress Asia

Sean Hall (CEO) recently presented on Medlab's NanoCelle Delivery platform at The University of Sydney’s BioNanoTechnology and Biomedical Engineering summer school.

NanoCelle Delivery Platform

Congratulations to the Medlab team! Best early-phase chronic disease drug discovery company. Click the link to review the article, featured on pages 16 and 17.

Best Early-Phase Chronic Disease Drug Discovery Company Award

Medlab's research featured on Channel 9 news

Medlab Clinical is at the forefront of research into obesity and the prevention of diabetes. Medlab's probiotic formulation is currently undergoing clinical trial evaluation in collaboration with the University of Sydney's Boden Institute as featured in a recent Channel 9 news item.

Watch Interview